The American Motorcyclist Association (AMA) has named the Pediatric Brain Tumor Foundation the 2022 Recreational Road Riding Organizer of the Year. AMA’s annual Racing and Organizer Awards recognize standout individuals and organizations from AMA-sanctioned competition and recreational endeavors for their profound impact in the motorcycling community.

The longest-running national motorcycle charity program, the Pediatric Brain Tumor Foundation’s Ride for Kids provides road and offroad riders, racers, groups, and members of the moto industry the opportunity to help families facing the deadliest childhood disease: pediatric brain cancer.

“The Pediatric Brain Tumor Foundation is honored to receive this award, which would not be possible without the support of American Honda, the Comoto Family of Brands, our partners in the powersports community, and every Ride for Kids volunteer and fundraiser,” says Bob McNamara, the Pediatric Brain Tumor Foundation’s Director of Ride for Kids. “This recognition reflects the vibrant community our supporters have helped us build and the difference they make in families’ lives. We’re grateful for the passion, ingenuity, and determination they bring to Ride for Kids year after year.”

For over three decades, Ride for Kids has raised money to fund pediatric brain tumor research and provide financial, educational, and emotional support to patients and families throughout their cancer journey. In 2022, the Ride for Kids community raised over $1.4 million in support of the Pediatric Brain Tumor Foundation’s mission.

This fundraising remains critical to ending the childhood cancer community’s biggest crisis. A report released in September revealed that more children are diagnosed and dying from brain tumors than any other cancer. In response, the Pediatric Brain Tumor Foundation is redoubling its commitment to fund promising early-stage research, advocating at the state and federal levels for childhood cancer policies, and directing family support resources where each dollar makes the most difference.

Ride for Kids fundraisers are the fuel for this work, and in 2023 there will be more ways than ever to make a difference. The Pediatric Brain Tumor Foundation is partnering with powersports industry brands, community events and riders to create new opportunities throughout the year to help families.

Attendees of next week’s AIMExpo Powersports Tradeshow in Las Vegas can visit booth #1016 or stop by the Dealernews Top 100 Celebration and AIMExpo Media Luncheon for a first look at the Pediatric Brain Tumor Foundation’s plans for this year’s Ride for Kids. You can also learn more by filling out the Ride for Kids interest form at www.curethekids.org/rideforkids.  AMA’s complete list of racing and organizer awardees can be found in their press release here.

About the Pediatric Brain Tumor FoundationSince 1991, the Pediatric Brain Tumor Foundation’s research funding, advocacy, and family support have led the way in ending the childhood cancer community’s biggest crisis. Dedicated wholly to addressing this rare, but devastating disease and guided by the experiences of patients, survivors, their parents, and siblings, the Pediatric Brain Tumor Foundation is the only organization to meet families’ needs along every step of their cancer journey.

The largest patient advocacy funder of pediatric brain tumor research, the foundation also funds and advocates for innovative projects that lead to vital discoveries, new clinical trials, and better treatments – all bringing us closer to a cure. We’re able to do that because of people and partners committed to supporting families and ending childhood brain cancer. Learn more at www.curethekids.org.

 

Related Updates

Pediatric Brain Tumor Foundation Awards More Than $1 Million in New Research Funding to Dana-Farber Cancer Institute

Research News

Pediatric Brain Tumor Foundation Awards More Than $1 Million in New Research Funding to Dana-Farber Cancer Institute

The Pediatric Brain Tumor Foundation (PBTF) proudly announces an infusion of $1 million to help researchers, led by Dana-Farber Cancer Institute’s Drs. Pratiti (Mimi) Bandopadhayay and Rameen Beroukhim, launch a study into a novel therapeutic target and expand their research into overcoming treatment resistance and rebound growth.

Urgent Action Needed: Congressional Hearing on Accelerating Kids’ Access to Care Act

Advocacy Alert

Urgent Action Needed: Congressional Hearing on Accelerating Kids’ Access to Care Act

Recently, the Accelerating Kids' Access to Care Act gained significant momentum in Congress when Charlie, a 12-year-old brain tumor survivor and advocate with the Pediatric Brain Tumor Foundation, testified to the U.S. Senate Finance Committee about the hurdles families face when seeking treatment for their child. Now, to see it become law requires your immediate action.

Name(Required)
This field is for validation purposes and should be left unchanged.